Lene B. Oddershede to head Novo Nordisk Foundation's grants for research in the natural and technical sciences - Novo Nordisk Fonden
Corvidia Therapeutics is sold to Novo for $2.1B | 2020-06-11 | BioWorld
Novo Nordisk sees huge rise in first nine months sales
Novo Nordisk to buy sickle cell disease biotech Forma Therapeutics in $1.1B deal - MedCity News
NOVO NORDISK A/S : NOVO B Stock Price | DK0060534915 | MarketScreener
From R&D to M&A: Novo Nordisk to Acquire Dicerna for $3.3B
Novo Nordisk's long-acting haemophilia B drug cleared by FDA - PMLiVE
ar_001.jpg
Novo Nordisk shells out $1.1B for Forma, sickle cell drug – PharmaLive
Novo Nordisk to Sell Discount Insulin After Criticism Over Price - Bloomberg
MEDIA B-ROLL : Novo Nordisk insulin manufacturing facility, Claros, Brazil
Abbott and Novo Nordisk to offer integrated solution for diabetes
Novo Nordisk (NVO) Stock: Attractive Market But Likely No Margin Of Safety | Seeking Alpha
Novo Nordisk (NYSE: NVO) will build a $1.2 billion manufacturing facility in Johnston County and add 691 jobs - Triangle Business Journal
Novo Nordisk pauses trials in haemophilia A and B - Nordic Life Science – the leading Nordic life science news service
Buy Novo Nordisk B A/S stock & View ($NOVO-B.CO) Share Price on eToro.
Novo Nordisk CEO: Very upbeat on outlook for 2022
Novo Nordisk (NOVO-B) hit by drop in insulin sales in China
Novo Nordisk, underway with key launches, reveals $2.58B manufacturing investment | Fierce Pharma
Rejected Again: Ablynx Turns Down Novo Nordisk's Sweetened $3.1B Bid | BioSpace
Novo Nordisk plots $1.3B in spending as it expands API production—and advances new oral meds | Fierce Pharma
